EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colchicine has Dose‐Dependent Therapeutic Effects in a LPS ‐Induced Experimental Endotoxemia Model

Meliksah Demir iD, Ayse Yesim Gocmen, Esin Ozcelebi, Zuleyha Doganyigit, Aslı Okan Oflamaz, Alper Bektas Iskit iD

Pharmacology Research & Perspectives · 2026-04 · 14 (2)

DOI: 10.1002/prp2.70239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 06.04.2026. Verfasst von Meliksah Demir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Colchicine, Endotoxemia, Anti-Inflammatory Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colchicine is an ancient medication that has long been used for anti‐inflammatory properties. Because of unfavorable and toxic consequences of colchicine, selecting an appropriate dose is critical. The effects of three different doses (0.5, 1 or 5 mg/kg) of colchicine were evaluated. To stimulate systemic inflammation, we created an LPS‐induced experimental endotoxemia model with 1 mg/kg LPS intraperitoneal injection. Possible therapeutic effects of colchicine were investigated on cytokines, decreased mesenteric artery blood flow and histopathological damage scores. Treatment with 1 mg/kg colchicine reduced the pro‐inflammatory cytokines IL‐1β, TNF‐α, IL‐8, and IL‐17 to levels comparable to the control group and attenuated the damage caused by LPS in liver and spleen tissues. At a dose of 0.5 mg/kg, colchicine was not able to decrease cytokine levels to those of the control group. In contrast, administration of 5 mg/kg colchicine ameliorated mesenteric blood flow; however, this higher dose caused an increase in cytokine levels. Among three different colchicine doses, 1 mg/kg intraperitoneal dose significantly improved the inflammatory indices and may be considered a suitable option for anti‐inflammatory treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineEndotoxemiaAnti-Inflammatory AgentsAnimalsLipopolysaccharidesMaleDose-Response Relationship, DrugCytokinesDisease Models, AnimalLiverMesenteric ArteriesRatsSpleenInjections, Intraperitoneal

Stichwörter der Autor:innen

LPS‐induced endotoxemiaanti‐inflammatory effectcolchicinemesenteric artery blood flowmultiple organ damage

Substanzen

ColchicineLipopolysaccharidesAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
  • Department of Histology and Embryology, Bozok University, Yozgat, Turkey.

ORCID-Profile: Meliksah Demir, Alper Bektas Iskit

Förderung

  • Hacettepe Üniversitesi

Zitieren

APA

Demir, M., Gocmen, A. Y., Ozcelebi, E., Doganyigit, Z., Oflamaz, A. O., & Iskit, A. B. (2026). Colchicine has Dose‐Dependent Therapeutic Effects in a LPS ‐Induced Experimental Endotoxemia Model. Pharmacology Research & Perspectives, 14(2). https://doi.org/10.1002/prp2.70239

Vancouver

Demir M, Gocmen AY, Ozcelebi E, Doganyigit Z, Oflamaz AO, Iskit AB. Colchicine has Dose‐Dependent Therapeutic Effects in a LPS ‐Induced Experimental Endotoxemia Model. Pharmacology Research & Perspectives. 2026;14(2). doi:10.1002/prp2.70239

BibTeX
@article{Demir2026,
  author = {Demir, Meliksah and Gocmen, Ayse Yesim and Ozcelebi, Esin and Doganyigit, Zuleyha and Oflamaz, Aslı Okan and Iskit, Alper Bektas},
  title = {Colchicine has Dose‐Dependent Therapeutic Effects in a LPS ‐Induced Experimental Endotoxemia Model},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/prp2.70239}
}
Kostenlos starten →